Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

0395 Effects of Insomnia and Rest-Activity on Hospitalizations and Emergency Department Visits in People with Stable Heart Failure
O’Connell, Meghan , Tocchi, Christine , Jeon, Sangchoon , Conley, Samantha , Hollenbeak, Christopher S. , Yaggi, Henry Klar , Jacoby, Daniel Louis , Wang, Zequan , Redeker, Nancy S.

Mayo Clinic

SLEEP | May 29, 2023 | Volume: 46 | Issue: Supplement_1 | Pages: A175-A175

10.1093/sleep/zsad077.0395 Get It

Abstract Introduction People with heart failure (HF) have frequent hospitalizations, and emergency department (ED) visits. We examined the effects of insomnia and rest-activity rhythms (RARs) on time to hospitalizations and ED visits after controlling for other known risk factors among participants in a randomized controlled trial of cognitive behavioral therapy for insomnia compared to heart failure self-management education (attention control). Methods The analysis included 168 HF patients who had available medical records for dates of hospitalization, ED visit, transplant, and death from a randomized clinical trial for insomnia of people with HF and insomnia. The known risk factors included age, sex, New York Heart Association (NYHA) Class, ejection fraction, and comorbid conditions. We used the insomnia severity index (ISI) and evaluated the strength of RAR using the ratio of the amplitude to the MESOR estimated with cosinor analysis with activity counts from a wrist-actigraph worn for at least five consecutive days. Cox proportional hazard models were used to examine ­insomnia and the RAR metrics with the known risk factors on time to first hospitalization, ED visit, transplant, and death. Results Eighty-five (50.1%) had at least one hospitalization, and ninety-one (54.2%) participants had an ED visit. Approximately 42% of the participants were admitted to the hospital due to cardiac events. Older age, male sex, higher NYHA, and greater comorbidity were associated with earlier hospitalization or ED visits. After controlling for those risk factors, stronger RAR was associated with later time to hospitalization, and ED visit with hazard ratios (HRs) of 0.26 (95% CI=[0.07, 0.91]) and 0.25 (95% CI=[0.07, 0.89]); higher insomnia severity (ISI ≥22) was associated with shorter time to ED visits, with an HR of 2.28 (95% CI=[1.19, 4.38]). Conclusion In addition to known demographic and clinical risk factors, insomnia severity and RAR predict hospitalizations and ED visits in people with HF. Further research is necessary to assess the biological mechanism of the associations and examine whether the effects of the risk factors could be modified by improving insomnia severity and RAR in people with HF. Support (if any) This study was financially supported by grants R01NR016191 and P20NR014126 from NIH/NINR.
0326 Symptom trajectories in adults with stable heart failure and insomnia: Evidence from a randomized controlled trial of CBT-I
Wang, Zequan , Tocchi, Christine , Linsky, Sarah , O’Connell, Meghan , Conley, Samantha , Jeon, Sangchoon , Redeker, Nancy S.

Mayo Clinic

SLEEP | May 29, 2023 | Volume: 46 | Issue: Supplement_1 | Pages: A145-A145

10.1093/sleep/zsad077.0326 Get It

Abstract Introduction Cognitive behavioral therapy for insomnia (CBT-I) improves individual symptoms of fatigue and daytime sleepiness; however, little is known how CBT-I improves multiple co-occurring daytime symptoms. The purposes of this study are to (1) identify daytime symptom trajectories in adults with insomnia and stable chronic heart failure (HF) over one year, and (2) determine how symptom trajectories vary based on participation in CBT-I or HF self-management education (attention control condition). Methods We conducted a retrospective analysis of data from a randomized controlled trial that looked the sustained effects of CBT-I compared to HF self-management over one year (NCT02660385). We measured daytime symptoms (fatigue, depression, anxiety, dyspnea, pain, and daytime sleepiness) at baseline (pre-treatment) and 3, 6 and 12 months. Symptom cluster trajectory were identified using group-based trajectory modeling, and the association with CBT-I was examined using logistic regressions. Results We randomized 175 participants (M age=63.0 (12.9) years, 57% men). We found four daytime symptom cluster trajectories, (A) low improving symptoms (N = 67, 38.3%); (B) low psychological symptoms and high improving physical symptoms (N = 40, 22.8%); (C), high improving symptoms (N = 42, 24.0%); and (D) high not improving symptoms (N = 26, 14.9%). There was no statistically significant difference between CBT-I and HF self-management across 4 symptom trajectories (p = .2509). However, people who received CBT-I vs. HF self-management education had higher odds of belonging to trajectory A compared to B/C/D after controlling for baseline fatigue (OR = 3.27 95% Confidence Intervals [1.39, 7.68]). Conclusion Most participants experienced improved daytime symptom profiles over 12 months after both interventions. Participants in the CBT-I group experienced symptom improvement even when they started with low symptoms. Support (if any) National Institute of Nursing Research [R01NR016191 and P20NR014126].
A Novel AUC Maximization Imbalanced Learning Approach for Predicting Composite Outcomes in COVID-19 Hospitalized Patients
Wang, Guanjin , Kwok, Stephen Wai Hang, Yousufuddin, Mohammed , Sohel, Ferdous

Mayo Clinic

IEEE Journal of Biomedical and Health Informatics | May 25, 2023 | Volume: 27 | Issue: 8 | Pages: 3794-3805

10.1109/jbhi.2023.3279824 | PMID 37227914 Get It

Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer
Li, Shenduo , Correia, Guilherme Sacchi de Camargo, Wang, Jing , Zhao, Yujie , Lou, Yanyan , De Camargo Correia, Guilherme Sacchi, Manochakian, Rami

Mayo Clinic

Cancers | May 25, 2023 | Volume: 15 | Issue: 11 | Pages: 2899

10.3390/cancers15112899 | PMID 37296863 Get It

Lung cancer remains the leading cause of cancer-related mortality worldwide. Non-small-cell lung cancer (NSCLC) is the most common type and is still incurable for most patients at the advanced stage. Targeted therapy is an effective treatment that has significantly improved survival in NSCLC patients with actionable mutations. However, therapy resistance occurs widely among patients leading to disease progression. In addition, many oncogenic driver mutations in NSCLC still lack targeted agents. New drugs are being developed and tested in clinical trials to overcome these challenges. This review aims to summarize emerging targeted therapy that have been conducted or initiated through first-in-human clinical trials in the past year.
Machine-learning derived measures of vascular and brain age are independently associated with cognitive function
Iakunchykova, Olena , Leur, R Van De, Schirmer, Henrik , Vangberg, Torgil Riise , Wang, Y, Benavente, Ernest Diez , Es, René van , Lindekleiv, Haakon , López-Jiménez, Francisco , Leon, David A. , Wilsgaard, Tom

Mayo Clinic

European Journal of Preventive Cardiology | May 24, 2023 | Volume: 30 | Issue: Supplement_1 | Pages: No page available

10.1093/eurjpc/zwad125.134 Get It

Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): UiT The Arctic University of Norway, Northern Norway Regional Health Authority. Background/Introduction Machine learning models have been applied to magnetic resonance images of the brain to estimate brain age gap as a biomarker of biological aging. Because of its association with cognitive performance and neurological disorders, brain age gap has become an indicator of general brain health. Among others, cardiovascular risk factors are associated with brain health. Recently a novel non-invasive biomarker of vascular ageing has been proposed based on the application of a deep-learning algorithm to digitised 12-lead electrocardiograms. The difference between electrocardiogram predicted age and chronological age is defined as vascular age gap and has been shown to be associated with an adverse cardiovascular profile. However, the association of vascular age gap with cognitive health and dementias has not yet been examined. Purpose We apply a causal mediation framework to vascular age gap, brain age gap and cognitive function data obtained in the same individuals who took part in a population-based study in Norway. We hypothesise that cardiovascular risk factors encapsulated in vascular age gap can indirectly affect cognitive function by increasing the brain age gap. Methods We applied a deep learning algorithm (1) to electrocardiograms (N=7779, age 40-85 years) collected from the population-based sample in Norway (mean age 63.8 years, 45.3% men) to obtain a vascular age gap. For a subsample (N=1693) magnetic resonance images of the brain were also available and another deep neural network algorithm (2) was applied to obtain a biomarker of brain age. For 1678 participants with both vascular age gap and brain age gap available we used mediation analysis to test whether brain age gap mediates the effects of vascular age gap on cognitive function (as measured by mini mental status test, word memory test, digit–symbol coding test, tapping test) by estimating total, direct and indirect effects. Results We found a weak correlation (Pearson’s r = 0.12) between vascular age gap and brain age gap. Both age gaps were associated with cognitive scores capturing psychomotor speed, attention and mental flexibility. For a 1 standard deviation (7.3 years) increase in vascular age gap digit-symbol coding test score decreased by 0.63 (95%CI: -0.89, -0.36; p<0.001) points, and tapping test decreased by 0.36 (95%CI: -0.56, -0.14; p=0.001). Only 13% of effect of vascular age gap on cognitive test results was mediated by brain age gap. Conclusion(s) Vascular age gap was weakly associated with poorer cognitive functioning, and only 13% of this association was mediated by brain age gap. This suggests that cognitive decline linked to accumulated damage of the vascular system is not fully captured by structural changes in the brain. Further investigations of novel measures of biological aging in relation to cognitive decline are warranted as these may hold promise for improved understanding of mechanisms and clinical prediction.
Machine-Learning-Based Prediction Modelling in Primary Care: State-of-the-Art Review
Sherbini, Adham El , Glicksberg, Benjamin S. , Krittanawong, Chayakrit , Glicksberg, Benjamin , Virk, Hafeez Ul Hassan , Wang, Zhen

Mayo Clinic

AI | May 23, 2023 | Volume: 4 | Issue: 2 | Pages: 437-460

10.3390/ai4020024 Get It

Primary care has the potential to be transformed by artificial intelligence (AI) and, in particular, machine learning (ML). This review summarizes the potential of ML and its subsets in influencing two domains of primary care: pre-operative care and screening. ML can be utilized in preoperative treatment to forecast postoperative results and assist physicians in selecting surgical interventions. Clinicians can modify their strategy to reduce risk and enhance outcomes using ML algorithms to examine patient data and discover factors that increase the risk of worsened health outcomes. ML can also enhance the precision and effectiveness of screening tests. Healthcare professionals can identify diseases at an early and curable stage by using ML models to examine medical pictures, diagnostic modalities, and spot patterns that may suggest disease or anomalies. Before the onset of symptoms, ML can be used to identify people at an increased risk of developing specific disorders or diseases. ML algorithms can assess patient data such as medical history, genetics, and lifestyle factors to identify those at higher risk. This enables targeted interventions such as lifestyle adjustments or early screening. In general, using ML in primary care offers the potential to enhance patient outcomes, reduce healthcare costs, and boost productivity.
Cryo-EM structure of the Mon1–Ccz1–RMC1 complex reveals molecular basis of metazoan RAB7A activation
Yong, Xin, Jia, Guowen , Liu, Zhe , Zhou, Chunzhuang, Yi, Jiamin, Tang, Yingying , Chen, Li , Wang, Yuan , Sun, Qingxiang , Billadeau, Daniel D. , Su, Zhaoming , Sun, Qingxiang , Billadeau, Daniel D , Su, Zhaoming , Jia, Da , Yong, Xin, Yi, Jiamin, Chen, Lu , Jia, Da

Mayo Clinic

Proceedings of the National Academy of Sciences | May 22, 2023 | Volume: 120 | Issue: 22 | Pages: No page available

10.1073/pnas.2301725120 | PMID 37216550 Get It

Understanding of the evolution of metazoans from their unicellular ancestors is a fundamental question in biology. In contrast to fungi which utilize the Mon1–Ccz1 dimeric complex to activate the small GTPase RAB7A, metazoans rely on the Mon1–Ccz1–RMC1 trimeric complex. Here, we report a near-atomic resolution cryogenic-electron microscopy structure of the Drosophila Mon1–Ccz1–RMC1 complex. RMC1 acts as a scaffolding subunit and binds to both Mon1 and Ccz1 on the surface opposite to the RAB7A-binding site, with many of the RMC1-contacting residues from Mon1 and Ccz1 unique to metazoans, explaining the binding specificity. Significantly, the assembly of RMC1 with Mon1–Ccz1 is required for cellular RAB7A activation, autophagic functions and organismal development in zebrafish. Our studies offer a molecular explanation for the different degree of subunit conservation across species, and provide an excellent example of how metazoan-specific proteins take over existing functions in unicellular organisms.
Plain Language Summary of the MAIA Study of Daratumumab Plus Lenalidomide and Dexamethasone for the Treatment of People with Newly Diagnosed Multiple Myeloma
Kumar, Shaji , Plesner, Torben , Orlowski, Robert Z. , Hulin, Cyrille , Goldschmidt, Hartmut , Macro, Margaret , Leleu, Xavier , Wang, Jianping , Rampelbergh, Rian Van , Uhlar, Clarissa, Vermeulen, Jessica, Duran, Joana , Borgsten, Fredrik, Usmani, Saad Z. , Orlowski, Robert Z. , Usmani, Saad , Facon, Thierry T.F. , Moreau, Philippe , Bahlis, Nizar Jacques , Basu, Supratik , Nahi, Hareth , Quach, Hang , Perrot, Aurore , Weisel, Katja C , Raje, Noopur , Frenzel, Laurent

Mayo Clinic

Future Oncology | May 22, 2023 | Volume: 19 | Issue: 13 | Pages: 887-895

10.2217/fon-2023-0082 | PMID 37212642 Get It

Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease
Díaz, Alejandro A. , Orejas, J. , Grumley, Scott , Nath, Hrudaya , Wang, Wei , Yen, Andrew , Kligerman, Seth , Jacobs, Kathleen, Manapragada, Padma P. , Abozeed, Mostafa , Zahid, Mohd , Ahmed, Asmaa , Terry, Nina , Sonavane, Sushilkumar K. , Washko, George R. , Estépar, Raúl San Jośe , San Jose Estepar, Raul , Diaz, Alejandro A , Dolliver, Wojciech Remington , Yen, Andrew, Aziz, Muhammad Usman , Estépar, R. San José , Kim, Victor, Make, Barry J. , Han, MeiLan King , Cho, Michael H.

Mayo Clinic

JAMA | May 21, 2023 | Volume: 329 | Issue: 21 | Pages: 1832

10.1001/jama.2023.2065 | PMID 37210745 Get It

Importance Airway mucus plugs are common in patients with chronic obstructive pulmonary disease (COPD); however, the association of airway mucus plugging and mortality in patients with COPD is unknown. Objective To determine whether airway mucus plugs identified on chest computed tomography (CT) were associated with increased all-cause mortality. Design, Setting, and Participants Observational retrospective analysis of prospectively collected data of patients with a diagnosis of COPD in the Genetic Epidemiology of COPD cohort. Participants were non-Hispanic Black or White individuals, aged 45 to 80 years, who smoked at least 10 pack-years. Participants were enrolled at 21 centers across the US between November 2007 and April 2011 and were followed up through August 31, 2022. Exposures Mucus plugs that completely occluded airways on chest CT scans, identified in medium- to large-sized airways (ie, approximately 2- to 10-mm lumen diameter) and categorized as affecting 0, 1 to 2, or 3 or more lung segments. Main Outcomes and Measures The primary outcome was all-cause mortality, assessed with proportional hazard regression analysis. Models were adjusted for age, sex, race and ethnicity, body mass index, pack-years smoked, current smoking status, forced expiratory volume in the first second of expiration, and CT measures of emphysema and airway disease. Results Among the 4483 participants with COPD, 4363 were included in the primary analysis (median age, 63 years [IQR, 57-70 years]; 44% were women). A total of 2585 (59.3%), 953 (21.8%), and 825 (18.9%) participants had mucus plugs in 0, 1 to 2, and 3 or more lung segments, respectively. During a median 9.5-year follow-up, 1769 participants (40.6%) died. The mortality rates were 34.0% (95% CI, 32.2%-35.8%), 46.7% (95% CI, 43.5%-49.9%), and 54.1% (95% CI, 50.7%-57.4%) in participants who had mucus plugs in 0, 1 to 2, and 3 or more lung segments, respectively. The presence of mucus plugs in 1 to 2 vs 0 and 3 or more vs 0 lung segments was associated with an adjusted hazard ratio of death of 1.15 (95% CI, 1.02-1.29) and 1.24 (95% CI, 1.10-1.41), respectively. Conclusions and Relevance In participants with COPD, the presence of mucus plugs that obstructed medium- to large-sized airways was associated with higher all-cause mortality compared with patients without mucus plugging on chest CT scans.
Research using the Quality Outcomes Database: accomplishments and future steps toward higher-quality real-world evidence
Asher, Anthony L. , Haid, Regis W., Stroink, Ann R., Michalopoulos, Giorgos D. , Alexander, A. Yohan , Zeitouni, Daniel , Chan, Andrew K. , Virk, Michael S., Glassman, Steven D. , Foley, Kevin T. , Slotkin, Jonathan R., Potts, Eric A. , Shaffrey, Mark E., Shaffrey, Christopher I. , Upadhyaya, Cheerag D., Coric, Domagoj , Tumialán, Luis M. , Chou, Dean , Fu, Kai-Ming, Knightly, John J. , Orrico, Katie O., Wang, Michael Y. , Bisson, Erica F. , Mummaneni, Praveen V. , Bydon, Mohamad , Michalopoulos, Giorgos , Alexander, A Yohan , Virk, Michael S., Park, Paul

Mayo Clinic

Journal of Neurosurgery | May 20, 2023 | Volume: 139 | Issue: 6 | Pages: 1757-1775

10.3171/2023.3.jns222601 | PMID 37209070 Get It

OBJECTIVE The Quality Outcomes Database (QOD) was established in 2012 by the NeuroPoint Alliance, a nonprofit organization supported by the American Association of Neurological Surgeons. Currently, the QOD has launched six different modules to cover a broad spectrum of neurosurgical practice—namely lumbar spine surgery, cervical spine surgery, brain tumor, stereotactic radiosurgery (SRS), functional neurosurgery for Parkinson’s disease, and cerebrovascular surgery. This investigation aims to summarize research efforts and evidence yielded through QOD research endeavors. METHODS The authors identified all publications from January 1, 2012, to February 18, 2023, that were produced by using data collected prospectively in a QOD module without a prespecified research purpose in the context of quality surveillance and improvement. Citations were compiled and presented along with comprehensive documentation of the main study objective and take-home message. RESULTS A total of 94 studies have been produced through QOD efforts during the past decade. QOD-derived literature has been predominantly dedicated to spinal surgical outcomes, with 59 and 22 studies focusing on lumbar and cervical spine surgery, respectively, and 6 studies focusing on both. More specifically, the QOD Study Group—a research collaborative between 16 high-enrolling sites—has yielded 24 studies on lumbar grade 1 spondylolisthesis and 13 studies on cervical spondylotic myelopathy, using two focused data sets with high data accuracy and long-term follow-up. The more recent neuro-oncological QOD efforts, i.e., the Tumor QOD and the SRS Quality Registry, have contributed 5 studies, providing insights into the real-world neuro-oncological practice and the role of patient-reported outcomes. CONCLUSIONS Prospective quality registries are an important resource for observational research, yielding clinical evidence to guide decision-making across neurosurgical subspecialties. Future directions of the QOD efforts include the development of research efforts within the neuro-oncological registries and the American Spine Registry—which has now replaced the inactive spinal modules of the QOD—and the focused research on high-grade lumbar spondylolisthesis and cervical radiculopathy.